Andrew D. White

2.7k total citations · 2 hit papers
37 papers, 2.0k citations indexed

About

Andrew D. White is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Andrew D. White has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in Andrew D. White's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Andrew D. White is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Neuropeptides and Animal Physiology (5 papers). Andrew D. White collaborates with scholars based in United States, France and Poland. Andrew D. White's co-authors include Steven V. Ley, William P. Griffith, Guy Perkins, Akos A. Gerencser, Ella Bossy‐Wetzel, Blaise Bossy, Mark H. Ellisman, Jean‐Claude Martinou, Jiankun Cui and Hua Yuan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Andrew D. White

37 papers receiving 2.0k citations

Hit Papers

Preparation and use of tetra-n-butylammonium per-ruthenat... 1987 2026 2000 2013 1987 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. White United States 18 1.1k 666 260 224 222 37 2.0k
Alex M. Nadzan United States 26 1.7k 1.5× 673 1.0× 425 1.6× 303 1.4× 355 1.6× 68 2.9k
Donald S. Karanewsky United States 30 1.8k 1.6× 1.1k 1.6× 218 0.8× 76 0.3× 198 0.9× 77 3.0k
Alan L. Maycock United States 26 1.0k 0.9× 677 1.0× 219 0.8× 338 1.5× 191 0.9× 51 2.3k
Hiroyuki Miyachi Japan 28 1.1k 1.0× 665 1.0× 115 0.4× 110 0.5× 171 0.8× 93 2.1k
David A. Griffith United States 22 1.2k 1.1× 880 1.3× 247 0.9× 349 1.6× 54 0.2× 52 2.5k
Heather Hoover United States 15 1.5k 1.3× 361 0.5× 159 0.6× 120 0.5× 475 2.1× 17 2.3k
Michael J. Coghlan United States 27 1.1k 0.9× 735 1.1× 361 1.4× 136 0.6× 75 0.3× 57 2.3k
Andrew J. Souers United States 30 2.0k 1.7× 685 1.0× 105 0.4× 241 1.1× 215 1.0× 79 3.1k
Hongyu Zhao United States 23 1.1k 1.0× 704 1.1× 65 0.3× 130 0.6× 147 0.7× 70 2.1k
Philip V. LoGrasso United States 38 2.7k 2.3× 900 1.4× 332 1.3× 288 1.3× 231 1.0× 79 4.0k

Countries citing papers authored by Andrew D. White

Since Specialization
Citations

This map shows the geographic impact of Andrew D. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. White more than expected).

Fields of papers citing papers by Andrew D. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. White. The network helps show where Andrew D. White may publish in the future.

Co-authorship network of co-authors of Andrew D. White

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. White. A scholar is included among the top collaborators of Andrew D. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. White. Andrew D. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Adriana, Sylviane Lambert, Catherine Luke, et al.. (2023). The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor. Blood. 142(18). 1556–1569. 9 indexed citations
2.
Çakır, Işın, Rushita A. Bagchi, Masoud Ghamari‐Langroudi, et al.. (2022). Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity. Nature Metabolism. 4(1). 44–59. 46 indexed citations
3.
Yu, Lei, Yu Wang, Sharon Singh, et al.. (2021). An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation. Blood. 138(18). 1691–1704. 15 indexed citations
4.
Liu, Xuwen, Michael W. Wilson, Kun Liu, et al.. (2020). Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidines as atypical protein kinase C inhibitors to control retinal vascular permeability and cytokine-induced edema. Bioorganic & Medicinal Chemistry. 28(11). 115480–115480. 1 indexed citations
5.
Yadav, Pramod Kumar, Victor Vitvitsky, Hanseong Kim, et al.. (2019). S-3-Carboxypropyl-l-cysteine specifically inhibits cystathionine γ-lyase–dependent hydrogen sulfide synthesis. Journal of Biological Chemistry. 294(28). 11011–11022. 15 indexed citations
6.
Chen, Bin, Chien‐An Chen, Darı́o Doller, et al.. (2014). cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(6). 1458–1461. 3 indexed citations
7.
Packiarajan, Mathivanan, Allen T. Hopper, Andrew D. White, et al.. (2013). Fused thiazolyl alkynes as potent mGlu5 receptor positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 23(14). 4037–4043. 6 indexed citations
8.
Packiarajan, Mathivanan, et al.. (2012). Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 22(20). 6469–6474. 12 indexed citations
9.
Packiarajan, Mathivanan, et al.. (2012). N-Aryl pyrrolidinonyl oxadiazoles as potent mGluR5 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 22(17). 5658–5662. 17 indexed citations
10.
Kushnareva, Yulia E., Akos A. Gerencser, Blaise Bossy, et al.. (2012). Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death and Differentiation. 20(2). 353–365. 92 indexed citations
11.
White, Andrew D. & Shaoyi Jiang. (2011). Hydration of Zwitterionic Glycine Betaine and Analogues Through Molecular Simulation. Biophysical Journal. 100(3). 212a–212a. 1 indexed citations
12.
Lǚ, Kai, Yu Jiang, Bin Chen, et al.. (2011). Strategies to lower the Pgp efflux liability in a series of potent indole azetidine MCHR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5310–5314. 11 indexed citations
13.
Johnson, Douglas S., Chung Sik Choi, David A. Favor, et al.. (2011). Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder. Bioorganic & Medicinal Chemistry Letters. 21(9). 2621–2625. 19 indexed citations
14.
Favor, David A., et al.. (2010). 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics. Bioorganic & Medicinal Chemistry Letters. 20(19). 5666–5669. 8 indexed citations
15.
Repine, Joseph T., Douglas S. Johnson, Andrew D. White, et al.. (2007). Synthesis of monofluorinated 1-(naphthalen-1-yl)piperazines. Tetrahedron Letters. 48(31). 5539–5541. 11 indexed citations
16.
Yuan, Hua, Akos A. Gerencser, Géraldine Liot, et al.. (2006). Nitric oxide‐induced mitochondrial fission is regulated by dynamin‐related GTPases in neurons. The EMBO Journal. 25(16). 3900–3911. 561 indexed citations breakdown →
17.
Johnson, Linda L., A.G. Pavlovsky, Adam R. Johnson, et al.. (2000). A Rationalization of the Acidic pH Dependence for Stromelysin-1 (Matrix Metalloproteinase-3) Catalysis and Inhibition. Journal of Biological Chemistry. 275(15). 11026–11033. 64 indexed citations
18.
Pavlovsky, A.G., Mark Williams, Daniel F. Ortwine, et al.. (1999). X‐ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: Implications for inhibitor selectivity. Protein Science. 8(7). 1455–1462. 65 indexed citations
19.
White, Andrew D., Thomas Bocan, Peter A. Boxer, Janet T. Peterson, & Denis J. Schrier. (1997). Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors. Current Pharmaceutical Design. 3(1). 45–58. 37 indexed citations
20.
White, Andrew D., et al.. (1980). A method utilizing human lymphocytes with in vitro metabolic activation for assessing chemical mutagenicity by sister-chromatid exchange analysis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 69(2). 283–291. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026